☆ 4.8 Editorial Material

No need for a large belly to have NASH

JOURNAL OF HEPATOLOGY (2011)

期刊

JOURNAL OF HEPATOLOGY

卷 54, 期 6, 页码 1090-1093

出版社

ELSEVIER

DOI: 10.1016/j.jhep.2011.01.010

关键词

Visceral obesity; Non-alcoholic steatohepatitis (NASH); Non-alcoholic fatty liver disease (NAFLD); Insulin resistance; Metabolic syndrome

类别

Gastroenterology & Hepatology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Biochemistry & Molecular Biology

The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review

Rodrigo Zamignan Carpi, Sandra M. Barbalho, Katia Portero Sloan, Lucas Fornari Laurindo, Heron Fernando Gonzaga, Paulo Cesar Grippa, Tereza L. Menegucci Zutin, Raul J. S. Girio, Claudia Sampaio Fonseca Repetti, Claudia Rucco Penteado Detregiachi, Patricia C. Santos Bueno, Eliana de Souza Bastos Mazuqueli Pereira, Ricardo de Alvares Goulart, Jesselina Francisco Dos Santos Haber

Summary: The use of probiotics, prebiotics, and symbiotics may be an important strategy for regulating the gut microbiota and improving NAFLD. Clinical trials have shown that interventions targeting the gut microbiota can improve various markers of NAFLD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease

Jeong Woo Kim, Chang Hee Lee, Baek-Hui Kim, Young-Sun Lee, Soon-Young Hwang, Bit Na Park, Yang Shin Park

Summary: This study aimed to evaluate the feasibility of using ultrasonography (US) for predicting non-alcoholic steatohepatitis (NASH) in patients with non-alcoholic fatty liver disease (NAFLD) and to develop various US indices combining US parameters and laboratory data for the detection of NASH. The results showed that the index combining gray-scale US parameters and AST had the best diagnostic performance for detecting NASH in NAFLD patients, suggesting its potential use as an alternative to liver biopsy.

QUANTITATIVE IMAGING IN MEDICINE AND SURGERY (2022)

添加到收藏夹

Article Nutrition & Dietetics

Dietary Long-Chain Fatty Acids Accelerate Metabolic Dysfunction in Guinea Pigs with Non-Alcoholic Steatohepatitis

Kamilla Pedersen, David Hojland Ipsen, Josephine Skat-Rordam, Jens Lykkesfeldt, Pernille Tveden-Nyborg

Summary: This study investigated the effects of high-fat diets based on coconut oil or cocoa butter on glucose homeostasis and NASH in guinea pigs. The results showed that a diet high in long-chain fatty acids (LCFA) promoted metabolic imbalance and accelerated NASH-associated hepatic fibrosis. The study highlights the importance of evaluating fatty acid composition when investigating NASH-related endpoints.

NUTRIENTS (2023)

添加到收藏夹

Review Immunology

Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease

Maria Luz Martinez-Chantar, Teresa C. Delgado, Naiara Beraza

Summary: NAFLD is the most common form of chronic liver disease, with NASH representing an advanced stage. NK cells play a key role in supporting hepatic inflammation in NASH, with research showing differential functions in different environments. Therapeutic approaches based on the modulation of NK cells show potential in managing NASH progression.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Food Science & Technology

Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)

Nelson Kei, Vincent Wai Sun Wong, Susana Lauw, Lijun You, Peter Chi Keung Cheung

Summary: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with no approved drug treatment. This review focuses on preclinical animal studies that demonstrate the beneficial effects of food-derived beta-glucan in preventing and treating NAFLD. Beta-glucan shows hepatoprotective, anti-steatotic, anti-inflammatory, anti-fibrotic, and antioxidant activities, and may function through its impact on gut microbiota and metabolites.

FOODS (2023)

添加到收藏夹

Article Immunology

Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum

Hsuan-Wei Chen, Jung-Chun Lin, Ying-Hsuen Wu, Yi-Lin Chiu

Summary: The study revealed that patients with XP have a higher risk of developing NAFLD and exhibit more severe dyslipidemia.

JOURNAL OF INFLAMMATION RESEARCH (2021)

添加到收藏夹

Review Medicine, General & Internal

Predictors of patient survival following liver transplant in non-alcoholic steatohepatitis: A systematic review and meta-analysis

Adam Minich, Fakhar Ali Qazi Arisar, Noor-ul Saba Shaikh, Leanne Herman, Amirhossein Azhie, Ani Orchanian-Cheff, Keyur Patel, Sareh Keshavarzi, Mamatha Bhat

Summary: This study conducted a systematic review and meta-analysis to identify clinical variables that predict post-liver transplantation survival in non-alcoholic steatohepatitis (NASH) patients. The findings provide valuable insights for optimizing patient outcomes and decision-making in the limited-resource liver transplantation setting.

ECLINICALMEDICINE (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research

Christina-Maria Flessa, Narjes Nasiri-Ansari, Ioannis Kyrou, Bianca M. Leca, Maria Lianou, Antonios Chatzigeorgiou, Gregory Kaltsas, Eva Kassi, Harpal S. Randeva

Summary: Due to the adoption of western-type lifestyles and eating habits, the incidence of non-alcoholic fatty liver disease (NAFLD) has been rapidly increasing worldwide. This highlights the need to understand the molecular mechanisms driving the pathogenesis of this chronic disease and develop new approved treatments. Animal models play a crucial role in achieving these goals. Although there is no perfect mouse model for human NAFLD yet, several models have been developed through dietary interventions, genetic manipulations, and/or administration of chemical substances. In this article, we present the most commonly used mouse models in NAFLD research, for the entire disease spectrum or for specific stages. We also discuss the advantages and disadvantages of each model, as well as the challenges faced by researchers aiming to develop and use animal models for translational research in NAFLD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Endocrinology & Metabolism

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets

Yinshuang Chen, Weipeng Wang, Maria P. Morgan, Tracy Robson, Stephanie Annett

Summary: Obesity is a global epidemic and is strongly associated with an increased risk of hepatocellular carcinoma (HCC), the third leading cause of cancer deaths worldwide. The development of obesity-associated HCC starts from nonalcoholic fatty liver disease (NAFLD), progresses to nonalcoholic steatohepatitis (NASH), cirrhosis, and eventually to HCC. This review provides a comprehensive overview of the molecular mechanisms and cellular signaling pathways involved in the pathogenesis of obesity-associated HCC, as well as the available experimental models and diagnostic methods. The discussion also includes novel therapeutic targets and ongoing clinical trials for obesity-associated HCC.

FRONTIERS IN ENDOCRINOLOGY (2023)

添加到收藏夹

Article Endocrinology & Metabolism

Therapeutic approaches for non-alcoholic steatohepatitis

Luc F. Van Gaal, Jonathan Mertens, Sven Francque, Christophe De Block

Summary: NAFLD and NASH are emerging global epidemics often associated with obesity, metabolic syndrome, and type 2 diabetes. Despite ongoing developments in pharmacotherapies, lifestyle intervention remains the most effective and approved therapeutic option. More focus should be placed on prevention of this disease entity.

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease

Luca Valenti, Federica Pedica, Massimo Colombo

Summary: Hepatocellular carcinoma (HCC) is increasing globally, with nonalcoholic fatty liver disease (NAFLD) being a major contributing factor. NAFLD-related HCC has a higher incidence rate in the Far East, associated with the obesity and diabetes epidemic. NAFLD-HCC is frequently associated with cardiovascular comorbidities, absence of cirrhosis in some patients, and persistently normal transaminase values.

DIGESTIVE AND LIVER DISEASE (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis

Gregory Habig, Christa Smaltz, Dina Halegoua-DeMarzio

Summary: This review explores the relationship between NASH and sarcopenia, highlighting their mutual interactions within the scope of metabolic syndrome, and emphasizes the importance of assessing muscle mass, strength, and functionality for improved diagnosis and management in patients with sarcopenia and NASH.

METABOLITES (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease mediates the effect of obesity on arterial hypertension

Carlos J. Pirola, Silvia Sookoian

Summary: This study found that non-alcoholic fatty liver disease (NAFLD) mediates the relationship between obesity and arterial hypertension.

LIVER INTERNATIONAL (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Role of Leptin in Non-Alcoholic Fatty Liver Disease

Carlos Jimenez-Cortegana, Alba Garcia-Galey, Malika Tami, Pilar del Pino, Isabel Carmona, Soledad Lopez, Gonzalo Alba, Victor Sanchez-Margalet

Summary: NAFLD affects a quarter of the global population and poses a significant health and economic burden across all countries. The lack of approved pharmacotherapy and well-established diagnostic strategies for this disease highlights the urgency for further research and management efforts. Studies have shown a strong relationship between the hormone leptin and the development of NAFLD, suggesting potential advancements in disease management through further investigation of its role.

BIOMEDICINES (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis

Abdulrahman Ismaiel, Ayman Jaaouani, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu

Summary: The study suggests that the VAI has predictive value in diagnosing NAFLD and NASH, particularly showing significantly increased values in adult NAFLD patients, simple steatosis compared to controls, and severe steatosis compared to simple steatosis.

BIOMEDICINES (2021)

添加到收藏夹

Article Medicine, General & Internal

Prevalence and risk factors of fatty liver in Portuguese adults

Jorge Leitao, Sofia Carvalhana, Joana Cochicho, Ana Paula Silva, Francisco Velasco, Isabel Medeiros, Ana Catarina Alves, Mafalda Bourbon, Barbara Oliveiros, Vitor Rodrigues, Rita Sousa, Filipa Sampaio, Armando Carvalho, Helena Cortez-Pinto

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)

添加到收藏夹

Article Urology & Nephrology

Organ donation and transplantation: a multi-stakeholder call to action

Raymond Vanholder, Beatriz Dominguez-Gil, Mirela Busic, Helena Cortez-Pinto, Jonathan C. Craig, Kitty J. Jager, Beatriz Mahillo, Vianda S. Stel, Maria O. Valentin, Carmine Zoccali, Gabriel C. Oniscu

Summary: While Europe has higher overall donation and transplantation activity compared to other continents, there are significant differences between European countries in various aspects of transplantation. Policy and clinical measures are necessary to increase access to transplantation and improve post-transplantation outcomes. Recommendations for advancements in organ donation and transplantation within the European Union are proposed in a Roadmap developed by key stakeholders in the field.

NATURE REVIEWS NEPHROLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Outcomes of excessive alcohol drinkers without baseline evidence of chronic liver disease after 15 years follow-up: Heavy burden of cancer and liver disease mortality

Sonia Bernardo, Ricardo Crespo, Sofia Saraiva, Rui Barata, Sara Goncalves, Paulo Nogueira, Helena Cortez-Pinto, Mariana Verdelho Machado

Summary: The study shows that 6% of long-term heavy drinkers without evidence of chronic liver disease progressed to CLD, with cancer being the main cause of death. Abstinence for at least 1 year was positively associated with both CLD-free survival and overall survival.

PLOS ONE (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease

Helena Cortez-Pinto, Rodrigo Liberal, Susana Lopes, Mariana Machado, Joana Carvalho, Teresa Dias, Arsenio Santos, Claudia Agostinho, Pedro Figueiredo, Rafaela Loureiro, Alexandra Martins, Goncalo Alexandrino, Isabel Cotrim, Carina Leal, Jose Presa, Monica Mesquita, Joana Nunes, Catarina Gouveia, Ana Horta E. Vale, Ana Luisa Alves, Mariana Coelho, Luis Maia, Isabel Pedroto, Antonio Banhudo, Joao Sebastiao Pinto, Marta Vargas Gomes, Joana Oliveira, Valeska Andreozzi, Filipe Calinas

Summary: This study found a considerable proportion of patients with primary biliary cholangitis showed incomplete biochemical response to ursodeoxycholic acid (UDCA) treatment. Patients with cirrhosis, elevated levels of gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP) at diagnosis were identified as being at higher risk for incomplete response. Early identification of patients at risk of incomplete response could improve treatment care and guide clinical decision-making.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

Meritxell Ventura-Cots, Josepmaria Argemi, Patricia D. Jones, Carolin Lackner, Mohamed El Hag, Juan G. Abraldes, Edilmar Alvarado, Ana Clemente, Samitha Ravi, Antonio Alves, Mohamed Alboraie, Jose Altamirano, Sergio Barace, Francisco Bosques, Robert Brown, Juan Caballeria, Joaquin Cabezas, Sofia Carvalhana, Helena Cortez-Pinto, Adilia Costa, Delphine Degre, Carlos Fernandez-Carillo, Nathalie Ganne-Carrie, Guadalupe Garcia-Tsao, Joan Genesca, John Koskinas, Nicolas Lanthier, Alexandre Louvet, Juan Jose Lozano, Michael R. Lucey, Steven Masson, Philippe Mathurin, Nahum Mendez-Sanchez, Rosa Miquel, Christophe Moreno, Taofic Mounajjed, Gemma Odena, Won Kim, Pau Sancho-Bru, R. Warren Sands, Justyna Szafranska, Laurine Verset, Bern Schnabl, Christine Sempoux, Vijay Shah, Debbie Lindsay Shawcross, Rudolf E. Stauber, Beate K. Straub, Elizabeth Verna, Dina Tiniakos, Eric Trepo, Victor Vargas, Candid Villanueva, John T. Woosley, Marianne Ziol, Sebastian Mueller, Peter Starkel, Ramon Bataller

Summary: Despite comparable alcohol intake, AH patients presented with worse liver function compared with ndALD patients. Bilirubinostasis, severe fibrosis and ductular reaction were prominent features of AH. AH patients exhibited a more profound deregulation of gene expression compared with ndALD patients.

GUT (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Advancing the global public health agenda for NAFLD: a consensus statement

Jeffrey Lazarus, Henry E. Mark, Quentin M. Anstee, Juan Pablo Arab, Rachel L. Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M. Ashworth Dirac, Sven Francque, Jacob George, Hannes Hagstrom, Terry T-K Huang, Mona H. Ismail, Achim Kautz, Shiv Kumar Sarin, Rohit Loomba, Veronica Miller, Philip N. Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary Rinella, Diana Romero, Manuel Romero-Gomez, Jorn M. Schattenberg, Emmanuel A. Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M. Younossi, Shira Zelber-Sagi

Summary: Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects a significant portion of the global adult population, but has received little attention from the global public health community. This has led to a lack of inclusion of NAFLD in national and international strategies and policies for non-communicable diseases, highlighting the need for a more comprehensive public health response to the disease.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

添加到收藏夹

News Item Gastroenterology & Hepatology

My UEG Presidency: Providing opportunities for professionals to enhance their knowledge and skills and ultimately contribute to the improvement of digestive health

Helena Cortez-Pinto

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

NAFLD Nutritional Management: Results from a Multidisciplinary Approach

Sara Raquel Osorio Policarpo, Mariana V. Machado, David Barreira, Helena Cortez-Pinto

Summary: This study focused on a 12-month lifestyle intervention for NAFLD patients, showing that the multidisciplinary treatment group had significantly greater weight loss and maintenance outcomes, as well as significant differences in liver enzymes compared to the conventional treatment group.

GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY (2022)

添加到收藏夹

Article Nutrition & Dietetics

Do MAFLD Patients with Harmful Alcohol Consumption Have a Different Dietary Intake?

Sara Policarpo, Sofia Carvalhana, Ana Craciun, Ricardo Rios Crespo, Helena Cortez-Pinto

Summary: This study aimed to assess the dietary intake of metabolic-associated fatty liver disease (MAFLD) patients and explore the relationship between its inflammatory characteristics, liver fibrosis, and alcohol intake. The results showed that alcohol intake was associated with higher energy and certain nutrient intake, but there was no correlation between fibrosis severity or alcohol consumption and inflammatory characteristics.

NUTRIENTS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry

Einar S. Bjornsson, Camilla Stephens, Edmond Atallah, Mercedes Robles-Diaz, Ismael Alvarez-Alvarez, Alexander Gerbes, Sabine Weber, Guido Stirnimann, Gerd Kullak-Ublick, Helena Cortez-Pinto, Jane Grove, M. Isabel Lucena, Raul J. Andrade, Guruprasad P. Aithal

Summary: This study is the first multi-national prospective DILI registry study in Europe, and it revealed that antibacterials were the most commonly implicated drugs in drug-induced liver injury, while antineoplastic and immunomodulating agents accounted for a higher proportion than previously described. This European initiative provides an important opportunity to advance the study on DILI.

LIVER INTERNATIONAL (2023)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

NAFLD, MAFLD and obesity: brothers in arms?

Mariana Verdelho Machado, Helena Cortez-Pinto

Summary: The year 2022 witnessed significant progress in both the NAFLD and obesity fields. Advancements in pharmacological treatment offer the potential for replacing bariatric surgery, while the application of artificial intelligence helps in evaluating histological effects of new drugs. Moreover, personalized screening for hepatocellular carcinoma in patients with NAFLD has also seen improvement.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Influence of COVID-19 on Patients with Esophageal Varices under Prophylactic Endoscopic Band Ligation Therapy

Ana Craciun, Ines Botto, Joao Lopes, Miguel Moura, Sofia Carvalhana, Helena Cortez-Pinto, Rui Tato Marinho

Summary: This study evaluated the impact of COVID-19 on the outcomes of patients receiving prophylactic endoscopic band ligation (EBL) therapy, including variceal eradication (VE), gastrointestinal bleeding (GI), and 6-month mortality. The results showed that COVID-19 had a negative effect on VE, and failure to achieve VE increased the risks of GI bleeding and 6-month mortality.

GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease

Samuel Raimundo Fernandes, Sonia Bernardo, Sofia Saraiva, Ana Rita Goncalves, Paula Moura Santos, Ana Valente, Luis Araujo Correia, Helena Cortez-Pinto, Fernando Magro

Summary: This study found that tight monitoring of inflammation and reactive treatment escalation can increase the rates of transmural remission in patients with Crohn's disease. Early intervention in the disease further improves these results.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn's Disease: A Propensity Score-Matched Analysis

Samuel Raimundo Fernandes, Sonia Bernardo, Sofia Saraiva, Ana Rita Goncalves, Paula Moura Santos, Ana Valente, Luis Araujo Correia, Helena Cortez-Pinto, Fernando Magro

Summary: This study suggests that proactive optimization of infliximab based on trough levels can increase the rates of transmural remission in Crohn's disease patients.

INFLAMMATORY BOWEL DISEASES (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib

Daniela Reis, Miguel Moura, Luis Carlos Freitas, Sofia Carvalhana, Paulo Jorge Nogueira, Raquel Gaio, Rui Tato Marinho, Helena Cortez-Pinto

Summary: A retrospective study of 77 advanced hepatocellular carcinoma patients found that Child-Pugh class A and absence of portal vein invasion were independent predictors of long-term survival. Sorafenib treatment can lead to over 2-year survival in a subgroup of patients.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.